George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 62,500 shares at $42.13 ($2.6M) on 2021-06-02, disclosed to the SEC on 2021-06-04.
Open-market sale of $2.6M RPRX by EVP, Investments & GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.09 | 12,500 | $526K | 20.0% |
| 2 | $42.13 | 50,000 | $2.1M | 80.0% |
| Total | $42.12 avg | 62,500 | $2.6M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |